Nobili, Flavio http://orcid.org/0000-0001-9811-0897
Schmidt, Reinhold
CarriĆ², Ignasi
Frisoni, Giovanni B.
Article History
First Online: 23 April 2018
Compliance with ethical standards
:
: Flavio Nobili: received personal fees and non-financial support from GE Healthcare, non-financial support from Eli-Lilly and grants from Chiesi Farmaceutici.Reinhold Schmidt: has nothing to declare.Ignasi CarriĆ²: has nothing to declare.Giovanni B Frisoni is principal investigator of industry-sponsored trials funded by AbbVie, Acadia, Altoida, Amoneta, Araclon, Biogen, Janssen, Novartis, Piramal; and has received funding for investigator-initiated trials from GE, Piramal, and Avid-Lilly; and has received speaker fees from a number of pharma and imaging companies.
: This article does not contain any new studies with human participants or animals performed by any of the authors. The human studies discussed herein come exclusively from previously published research articles.
: Not applicable, this is an Editorial.